Haemonetics | Des Atouts



Assets Changement Date
Avanos Medical USD 1.15B 502M 2024-12
Baxter International USD 25.78B 894M 2024-12
Becton, Dickinson and Co. USD 54.67B 2.62B 2024-12
Boston Scientific USD 39.4B 1.32B 2024-12
Cooper Companies USD 12.22B 93M 2025-01
Fresenius EUR 43.55B 1.18B 2024-12
Fresenius Medical Care EUR 33.57B 1.06B 2024-12
Globus Medical USD 5.25B 165.71M 2024-12
Haemonetics USD 2.53B 6.05M 2024-12
Hologic USD 8.73B 427.3M 2024-12
ICU Medical USD 4.2B 101.11M 2024-12
Intuitive Surgical USD 18.74B 999.8M 2024-12
Masimo USD 2.63B 462.1M 2024-12
Medtronic USD 89.97B 69M 2025-01
Merit Medical Systems USD 2.42B 40.52M 2024-12
Neogen USD 4.04B 17.76M 2025-02
Quidel USD 6.42B 377.5M 2024-12
ResMed USD 7.14B 81.08M 2024-12
STAAR Surgical USD 509.52M 28.07M 2024-12
Steris USD 10.01B 233.78M 2024-12
Stryker USD 42.97B 862M 2024-12
Teleflex USD 7.1B 388.38M 2024-12
Terumo JPY 1.88T 125.37B 2024-12
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12
US Physical Therapy USD 1.17B 138.28M 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12



Haemonetics Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.